The Valley Desk

NCT00892177 · Interventional trial

Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme

Overall registry status Completed

Phase 2

Conditions Glioblastoma Multiforme

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov